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Background: An imbalance of energy expenditure has been reported in Cystic Fibrosis (CF). High-energy diets, in combination with
pancreatic enzymes, do not always compensate for energy requirements. The aim of this study was to investigate the relation between Resting
Energy Expenditure (REE) and disease severity in CF.
Methods: REE was measured with indirect calorimetry in a group of 38 clinically stable CF patients (32 with pancreatic insufficiency and 6
with pancreatic sufficiency). Correlations between REE and pulmonary function as well as clinical status were studied.
Results: Increased REE expressed as a percentage of predicted (REE%) was demonstrated in pancreatic insufficient CF patients (PI) (113.3±
2.5%), as compared to pancreatic sufficient (98.9±2.5%) and healthy subjects. The elevated REE% in the PI group was not affected by
gender and exhibited a strong correlation with the clinical status of the patients (r=−0.641).
Conclusions: Our data analysis supports the argument that the percentage of predicted REE is an objective indicator of disease severity and
progression as well as energy requirements in the assessment of CF patients.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Resting energy expenditure1. Introduction
Undernutrition constitutes a common clinical manifestation
in Cystic Fibrosis (CF). In the past, undernutrition was mainly
attributed to inadequate food intake and malabsorption [1].
Microspheric pancreatic enzymes improve absorption, but do
not completely correct it. High-energy diets, in combination
with pancreatic enzymes, do not always compensate for
energy requirements. Therefore, approximately 16% of
children with CF are still found to be under the 5th percentage
for weight or height [2]. High resting energy expenditure may
be one component of energy imbalance in CF.⁎ Corresponding author. Agias Sofias 9, 57010 Pefka, Thessaloniki,
Greece. Tel.: +30 2310675051; fax: +30 2310580700.
E-mail address: tmod@med.auth.gr (T. Moudiou).
1569-1993/$ - see front matter © 2006 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2006.06.001Total energy expenditure of stable young adult CF
patients with moderately severe respiratory disease has
been reported to be comparable to that of a control
population. By contrast, Resting Energy Expenditure
(REE) was found to be increased [3]. REE is increased in
CF patients having no pulmonary infections, as compared to
controls or to values from prediction equations. REE
constitutes two thirds of the total daily energy expenditure.
The remaining third is the sum of the energy expenditure
related to physical activity, thermogenesis and growth in
children [4]. There has been controversy regarding the
relation of acute pulmonary exacerbation and REE. Several
studies [5] have reported that REE increases, while others
have supported lack of REE increase [6] during exacerba-
tions of lung disease in CF patients. It is not clear whether the
increase of REE reported in the literature is due to infectioned by Elsevier B.V. All rights reserved.
Table 1
Schofield H–W equations for estimating REE (kcal/day) from weight (W)
and height (H) in males and females
Age (year) Males Females
<3 0.167W+1517.4H−617.6 16.252W+1023.2H−413.5
3–10 19.59W+130.3H+414.9 16.969W+161.8H+371.2
10–18 16.25W+137.2H+515.5 8.369W+465.0H+200.0
>18 15.057W+10.04H+705.8 13.623W+283.0H+98.2
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the declining pulmonary function [7–11].
The aim of the present study was to clarify the relation
between REE and pulmonary function in clinically stable CF
patients who did not have pulmonary exacerbation; also to
investigate the concept that REE might serve as an indicator
of disease severity.
2. Methods
2.1. Patients
Thirty-eight Cystic Fibrosis (CF) patients, 19 males and
19 females ranging in age from 9 to 35 (19.72 S.E.M.±1.0)
years were investigated. The diagnosis of cystic fibrosis was
based on high sweat chloride concentrations on two
occasions and was confirmed by genotyping. Pancreatic
function was determined by fecal elastase-1 measurements.
These patients were attending the CF clinic regularly. None
of the patients had pulmonary exacerbation, gastrostomy
tube feeds or parenteral nutrition. Their clinical scores
expressed as Shwachman scores (SS) ranged from 74 to 96
(mean SS 87.0 S.E.M.±1.18). Thirty-two cystic fibrosis
patients had pancreatic insufficiency (CF-PI), whereas only 6
had pancreatic sufficiency (CF-PS). All the patients with PI
were receiving pancreatic enzyme replacement therapy.
Thirty-two patients had chronic pulmonary colonization
with pseudomonas and took inhalation antipseudomonas
antibiotic therapy regularly. None of the patients had
undergone transplantation. The lack of exacerbation was
verified on the basis of physical examination, C-reactive
protein (CRP), leukocyte and neutrophil counts.
2.2. Anthropometrical data
Body height (±0.1 cm) was measured in duplicate using a
SEGA stadiometer (Germany). Body weight (±0.1 kg) was
measured also in duplicate, while individuals were wearing
light clothing (only underwear), using an electronic floor
scale (SEGA model 713 max 130 kg, min 2 kg). All
measurements were performed by standardized techniques
[12,13]. Body Mass Index (BMI) was calculated from body
weight (kg) divided by height square (m2) and BMI z-scores
were obtained from the Center of Disease Control (CDC)
growth charts [14].
2.3. Measurement of Resting Energy Expenditure (REE)
REE was measured by open circuit indirect calorimetry
(JAEGER EOS-Sprint Oxygen Analyzer, Würzburg, Ger-
many) in the morning after an overnight fasting. A clear
facemask was placed for sampling respiratory gases at 35-s
intervals after a nose clip was placed. The patient rested in a
supine position for 35 min. The room temperature was stable
at 23 °C. Patients had taken all their medications in the
morning. The β2 agonist bronchodilators were taken at least12 h prior to the study. During this period, all individuals had
a short trial of mouthpiece breathing to familiarize with the
apparatus and protocol. They were observed closely for any
body movements. Measurements of REE obtained immedi-
ately after periods of coughing or body movements, which
might alter REE, were excluded. Respiratory gas exchanges
were monitored for 25 min. Steady state ventilation was
achieved, when the average changes of VO2 and VCO2 were
less than 10% and the average respiratory quotient changes
were less than 5% [15,16]. This was achieved in approxi-
mately 5 min in all cases. Otherwise the test was discarded
and repeated on a different day. The data obtained during the
initial 5-min period were discarded and measurements
during the remainder 20 min were averaged and used for
the calculation of oxygen uptake (VO2) and carbon dioxide
output. The modified Weir equation [17,18], REE=
[3.941⁎VO2+1.11⁎VCO2]⁎1.44, was used to calculate
energy equivalency from the oxygen consumption and the
carbon dioxide production. Before each procedure, the gas
analyzer was calibrated using a mixture of O2, CO2 and
nitrogen in precisely known concentrations.
REE measurements expressed in kilocalories per day
were compared to values from Schofield H–W prediction
equations. Schofield H–W prediction equations are consid-
ered as the most reliable to study individuals of different age,
sex and weight such as this group of patients [19–21]. These
equations were designed to estimate the energy needs of
healthy subjects in usual environmental and physical
conditions. They were first published by Schofield [19]
and are summarized in Table 1. The percentage of predicted
REE was calculated as follows: REE% ¼ Measured REE
Scholfield
 100.
When measured REE reached predicted REE, the percentage
of predicted REE (REE%) was 100%.
2.4. Evaluation of pulmonary status
Pulmonary function tests were performed following each
REE measurement applying a standard ergospirometer
(JAEGER EOS-Sprint Oxygen Analyzer, Wüzburg, Ger-
many). Forced Expiratory Volume in 1 s (FEV1), Forced
Vital Capacity (FVC) and Peak Expiratory Flow Rate
(PEFR) were expressed as percentage of that predicted for
height and sex. Chest X-ray films were evaluated at the
period of examination and scored [22]. Sputum culture
samples were obtained at the time of examination. Clinical
assessment was based on physical examination, leukocyte-
neutrophil counts, CRP and ferritin measurements, which
Table 2
Anthropometrics and respiratory status of CF patients included in the study
Pancreatic insufficiency Pancreatic
sufficiency
All
subjects
Males
(N=15)
Females
(N=17)
All
(N=6)
Age 19.6±1.0 19.8±1.58 19.41±1.4 21.5±3.3
Weight (kg) 52.15±2.0 54.3±3.12 50.25±2.67 70.8±6.26
BMI 19.7±0.5 19.42±0.74 19.93±0.72 25.6±2.06
BMI z-score −0.72±0.2 −1.03±0.32 −0.43±0.25 0.75±0.51
FEV1% 74.53±4.9 70.46±7.3 78.11±6.87 86.33±10.1
FVC% 78±4.4 75.8±6.83 80.0±5.8 90.1±9.9
Schwachman score 86.19±1.3 84.9±1.9 87.3±1.8 91.3±1.8
Fig. 1. Clinical scores (SS) were correlated with REE% in the CF-PI
subjects. The best fitted line; Pearson correlation coefficient and p-value are
depicted. It is clear that as SS decreases REE% increases. Correlation
between REE% and Shwachman clinical score (SS) was highly statistically
significant.
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REE study. SatO2 was checked with a pulse oximeter (BCI
International Waukes, HA Wisconcin Model 71000A1 Cat.
No. 3301) on the same day of REE measurement. Clinical
scores were determined according to Shwachman–Kulc-
zycki criteria [23].
2.5. Statistical analysis
Statistical analysis was performed using the SPSS
software package (version 11.0). Results were expressed as
mean±standard error (S.E.M.). Data of REE measurements
were compared with data of predicted REE from Schofield
H–W equations using a two-tailed paired Student's t-test.
The percentage of predicted REE (REE%) was compared
with a value of 100% using a two-tailed paired Student's t-
test.
Linear regression analysis was employed to investigate
the correlation between REE% and FEV1%, FVC%, PEFR%,
SatO2%, and Shwachman Clinical scores. The relative
Pearson correlation coefficient was calculated to further
analyze the relationship between energy expenditure and the
above-mentioned clinical data. The significance level was set
at p<0.05 and the confidence interval at 95%.
2.6. Ethical and legal considerations
This paper is part of the first author's medical thesis. A
Scientific Committee of the Department of Pediatrics,
Aristotle University of Thessaloniki, Greece reviewed theTable 3
Measured Resting Energy Expenditure (REE), predicted REE and percentage of p
Measured REE
(kcal/day)
Schofield
H–W
Meas
Scho
t
All (PI) 1611.6±52.9 1423.7±36.2 5.3
Males (PI) 1754.1±86.9 1564.7±48 3.3
Females (PI) 1485.9±47.6 1299.2±30.7 4.22
All (PS) 1702.3±132.8 1731.96±117.9 ns
⁎ ns: non-significant.protocol and approved the study before it was conducted
according to the tenets of the Helsinki Declaration.
3. Results
The anthropometrical characteristics and the data from
pulmonary function testing of the CF patients are shown in
Table 2.
Mean REE±S.E.M. was higher than predicted in CF
patients with pancreatic insufficiency (CF-PI), on the basis of
Schofield H–W prediction equations: 1611.6±52.9 as
opposed to 1423±36.2 (t=5.3, p=0.0001). REE% corre-
sponded to 113.3±2.5% (t=5.3, p=0.0001) of that predicted.
Mean REE values±S.E.M. in CF-PI males and females were
1754.1±86.9 and 1485.9±47.6, respectively. This corre-
sponded to REE% of 111.65±3.53% (t=3,3, p=0.005) and
114.56±3.6% (t=4.22, p=0.001), respectively (Table 3).
Although both CF-PI male and female patients had on
average a higher REE% than that predicted for a similar group
of healthy subjects, mean REE% for females was higher as
compared to that for males. However, this difference was not
statistically significant. The values of REE obtained from the
pancreatic sufficiency group were comparable to normal
(1702.3±132.8 and 1731.96±117.9 kcal/day, p>0.05).redicted REE (REE%) from Schofield H–W equations
ured REE versus
field
REE% REE% versus 100%
p t p
0.0001 113.3±2.5 5.35 0.0001
0.005 111.65±3.53 3.3 0.005
0.001 114±3.6 4.15 0.001
ns ⁎ 98.9±3.81 ns ns
Fig. 2. FEV1% was correlated with REE% in the CF-PI subjects. The best
fitted line; Pearson correlation coefficient and p-value are depicted.
Fig. 4. PEFR% was correlated with REE% in the CF-PI subjects. The best
fitted line; Pearson correlation coefficient and p-value are depicted.
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REE% in the CF-PI group had negative correlation with
FEV1%, FVC%, PEFR% and Shwachman clinical scores.
No correlation between REE% and SatO2 was found. No
statistical difference was found among males and females.
The Pearson correlation between REE and SS is depicted
in Fig. 1 (r=−0.641, p=0.0001 in CF-PI patients).
Correlation between REE% and FEV1% is demonstrated
in Fig. 2 (r=−0.474, p=0.006 in CF-PI patients).
Correlation between REE% and FVC% is shown in Fig. 3
(r=−0.570, p=0.001 in CF-PI patients). Finally, correla-
tion between REE% and PEFR% is depicted in Fig. 4 (r=
−0.41, p=0.021). It is clear that in the PI group, there is a
strong negative correlation between REE% and pulmonary
function as well as clinical status in general. In the CF-PI
group, REE% did not have significant correlation with
BMI z-scores, (r=0.18, p=0.32).
In the pancreatic sufficiency group (CF-PS), the correla-
tions between REE% and FEV1%, FVC%, PEFR% and
Shwachman clinical scores were not statistically significantFig. 3. FVC% was correlated with REE% in the CF-PI subjects. The best
fitted line; Pearson correlation coefficient and p-value are depicted.(REE versus SS: r=−0.398, p=0.43. REE% versus
FEV1%: r=−0.316, p=0.542, REE% versus FVC%: r=
−0.437 p=0.386). On the other hand, REE% demonstrated
significant negative correlation with the BMI z-scores (r=
−0.83, p=0.038).
4. Discussion
In the present study, REE was measured in CF patients
and REE values were related to the nutritional status and
pulmonary function. REE was found to be increased in CF
patients who had exocrine pancreatic insufficiency (CF-PI)
as opposed to those with sufficient exocrine pancreatic
function (CF-PS), whose REE values were comparable to
those predicted. Clinically stable CF-PI patients who had
similar pulmonary function with CF-PS individuals also
exhibited increased REE%. This observation supports the
argument that exocrine pancreatic function determines REE
% rather than the clinical status, which is also affected by
the pancreatic function. Elevated REE in CF-PI patients and
normal REE in CF-PS subjects was first reported by
O'Rawe et al. [24] and, also, by Fried et al. [11]. REE%
had a tendency to be higher in CF-PI females. However,
this did not reach statistical significance. REE differences
between male and female CF children with near normal
pulmonary function have been reported [25]. The effect of
gender is uncertain. It may explain, however, the inferior
growth of adolescent females and their overall shorter life
expectancy [25]. Younger CF-PI children were found to
have a tendency for lower REE% as compared to
adolescent and young adult individuals. However, REE in
younger patients was still higher than controls. This may be
attributed to the milder severity of the disease in younger
CF individuals.
BMI z-scores were applied to evaluate the nutritional
status of the CF patients, who were included in the study. As
expected, BMI z-scores were lower in CF patients, who had
exocrine pancreatic insufficiency, than those of pancreatic
sufficient patients, whose BMI z-scores were normal.
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ods. Pulmonary function tests were more impaired in the CF-
PI group than the CF-PS group. The difference was not
statistically significant. However, the PS group consisted of a
small sample for statistical analysis.
Again, as expected, the clinical status of the CF-PI group
was more affected than the CF-PS group. However, all CF
patients were on average in good clinical condition on the
basis of SS [23].
REE was found to have significant negative correlation
with BMI z-scores in CF-PS patients and poor correlation
with BMI z-score in the CF-PI group. This finding was
attributed to the fact that factors other than nutrition such as
type of CFTR gene mutation, frequent infections and
exocrine pancreatic function are involved. Allen et al. [25]
evaluated REE in a group of well-nourished CF patients of
both sexes and appropriate controls in order to assess
factors that may contribute to elevated energy expenditure
in the CF group. In regards to the factors that contributed to
REE in the CF population, multiple regression analysis
identified pancreatic function as a major variable. Normal
BMI scores are associated with normal or sufficient
pancreatic function.
There was strong negative correlation between REE and
pulmonary function in CF-PI group. This is in agreement
with previous studies. Vaisman et al. [8] reported that REE in
CF patients exceeded normal values and that the increase
correlated with a deterioration in lung function. Buchdahl et
al. [26] also demonstrated significant correlation between
increased REE values and poor pulmonary function. Fried et
al. [11] showed that REE in normally nourished boys and
men with cystic fibrosis was associated with declining
pulmonary function. By contrast, Zemel et al. [7] reported
that increased REE was not associated with declining
pulmonary function and that fat free mass and height were
the best predictions of REE. We have also found significant
correlation between REE and lean body mass [27,28].
Results in the CF-PS group did not reach statistical
significance.
In the CF-PI group, strong correlation between REE%
and Shwachman clinical score was demonstrated. REE%
increased as Shwachman score decreased as a result of the
progression of disease severity.
In conclusion, these data supported the fact that REE% is
increased in CF-PI patients. This study also demonstrated a
strong correlation between REE% and Shwachman clinical
score as well as pulmonary function. Furthermore, REE%
conveys information regarding energy needs and may be
helpful in early adjustment of the patient's diet.
Shwachman score has been applied in the assessment of
CF patient clinical status [29]. It is a relatively subjective
indicator and should be calculated by the same person [23].
When detailed evaluation of the clinical condition and
dietary interventions are needed, REE% is a reproducible
and objective indicator of the CF patient's condition, energy
requirements, disease severity and progression.References
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